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A SINGLE injection oftestosterone given to female rats in their early post-natal
life results in permanent morphological and functional changes of the gonado-
trophin-ovarian axis. The ovaries remain small and though they contain follicles
of various sizes, these do not rupture or produce any corpora lutea. Because of
the lack of ovulation, these androgenised rats are permanently sterile, and there
is a constant cornification of the vaginal epithelium. The luteinizing hormone
content ofthe pituitary is decreased (Barraclough, 1961 ; Gorski and Barraclough,
1962; Jacobsohn, 1964; Swanson and van der Werff ten Bosch, 1964; Kovaics,
1965).
As has been shown by Huggins, Grand and Brillantes (1961), Huggins and Yang
(1962) and other authors (Dao, 1962; Young, Cowan and Sutherland, 1963;
Daniel and Prichard, 1964) the intragastric administration of 9,10-dimethyl-1,2-
benzanthracene (DMBA) to normal female rats results in the development of
mammary tumours in a very high percentage of animals within a few months.
The present study is concerned with a comparison ofthe carcinogenic effect oforal
administration of DMBA in androgenised and in non-androgenised rats.
METHODS
Androgenisation was induced when the rats were 1 to 2 days old by a
single subcutaneous injection of 2-5 mg. testosterone propionate (Neo-Hombreol,
Organon) dissolved in 04 1 ml. oil. When the rats were between 45 and 55 days old,
DMBA dissolved in corn oil was administered orally through a gastric tube (a soft
rubber urethral catheter). The dose of DMBA will be mentioned later. The
animals were carefully palpated for mammary tumours at weekly intervals; a
tumour was recorded only when a nodule at least the size of a small pea could be
felt. The animals bearing the tumours died or were killed at various times up to 8
months. The tables show only the number ofrats with tumours; the number and
size of the tumours is not presented as these parameters would not provide valid
comparisons. The animals were killed with ether and autopsied as soon as pos-
sible. The tumours and the various organs were fixed in formol-saline and embed-
ded in paraffin. Sections at 5 It were stained with haematoxylin and eosin.
RESULTS
Experiment I.-This experiment was carried out on two groups (non-androgen-
ised and androgenised) of female rats of the Wistar strain. A single oral dose of
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50 mg. DMBA dissolved in 2 ml, corn oil was given. The results are shown in
Table I.
TABLE I
Non-androgenised rats
Number of Rats with mammianr
rats tumours
62 0
23 0
15 0
15 0
15 1
Extramaminary tumour:
colonic adenocarinoma
Androgenised rats
C---
Number of Rats with mainmarv
rats tumours
33 0
9 0
7 0
7 0
7
1
0
0
The rats tolerated the 50 mg. ofDMBA very badly. Many animals died early;
those that died in the first week or two commonly showed extensive adrenocortical
necrosis as described by Huggins and Morii (1961) Dao (1962), and Wong, Warner
and Yang (1962). In the non-androgenised rats only one mammary tumour was
found and no tumours at all occurred in the androgenised rats. This experiment
does not give any information concerning the effect of endocrine factors on the
development of mammary tumours, as the number of tumours and the number of
surviving animals was too small to allowevaluation ofthe results. Itwould appear
that the induction of mammary cancers cannot be studied satisfactorily in Wistar
rats using a single intragastric administration of 50 mg. DMBA. This dose is too
toxic, it is not well tolerated, and tumours of the breast develop only rarely in the
few animals which survive over 3 months. This conclusion is in essential agree-
ment with the findings of Engelbart and Gericke (1964).
Experiment II.-This experiment was also performed on non-androgenised and
androgenised female rats ofthe Wistar strain. DMBA was administered orally in
a dose of 10 mg. in 2 ml. corn oil twice weekly for a period of 3 weeks, so that each
rat received a total dose of 60 mg. of DMBA. The results of the experiment are
seen in Table II.
TABLE II
Non-androgenised rats
_.. ...-
Number of Rats with mammary
rats tumours
48 0
10 0
8 1
6 4
6 5
6 6
6 6
6 6
6 6
Extramammary tumours:
Stem cell leukaemia
Squamous carcinoma
Renal sarcoma
(embryonic type)
Colonic adenocarcinoma
Androgenised rats
Number of Rats with mammary
rats tumours
54 0
24 0
22 2
16 °
16 5
16 6
16 8
16 10
16 10
4
3
1
1
10
3
0
0
Days
0
30
60
120
150
Days
0
50
60
90
120
150
180
210
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Mammary tumours were present in all of the non-androgenised rats which
survived for 5 months after the beginning of the DMBA administration. Mam-
mary tumours also developed in the androgenised rats, but the incidence oftumours
was less and the time of appearance of the tumours was later.
The repeated small doses ofDMBA did not produce any necrosis ofthe adrenal
cortex. However, many ofthe animals died at 3 to 12 weeks after the first dose of
DMBA, and at autopsy it was found that some of them had enlargement of the
spleen, liver and lymph nodes. The organs looked very anaemic and petechiae
were present on the serous membranes. Histologically the liver and spleen were so
infiltrated with immature leucoblastic elements that their architecture was almost
totally destroyed (Fig. 1 and 2). Neoplastic foci consisting ofprimitive white cells
were also found occasionally in the renal cortex and in the adrenals (Fig. 3 and 4).
The diagnosis of stem cell leukaemia was confirmed by the examination of blood
films of some of the animals: the total leucocyte count was elevated and the
peripheral blood contained numerous primitive leucoblasts. The occurrence of
leukaemia in rats treated orally with DMBA has been previously reported by Dao
(1962) and Huggins and Yang (1962). There was no significant difference in the
incidence of leukaemia between the non-androgenised and androgenised rats.
Occasionally tumours developed in other organs. These are also listed in Table
II. The squamous cell carcinomata arose from the outer ear duct, apparently
from Zymbal's gland, a sebaceous gland located periauricularly near the tympanic
membrane (Fig. 5). Similar tumours have been described by other authors after
oral or intraniasal instillation of DMBA (Howell, 1960; Huggins, Grand and Bril-
lantes, 1961; Huggins and Yang, 1962), after oral administration of methyl-
cholanthrene (Kim andFurth, 1960a) or after painting the skin with an oilysolution
of DMBA (Howell, 1960).
Experiment 111.-This experiment was similar to Experiment I, except that
Sprague-Dawley rats were used. These were females and in two groups (non-
androgenised and androgenised). Each rat received 50 mg. DMBA dissolved in
2 ml. corn oil on one occasion when it was about 50 days old. The results are
presented in Table III.
TABLE III
Non-androgenised rats Androgenised rats
Number of Rats with mammary Number of Rats with mammary
Days rats tumours rats tumours
0 . 60 0 . 46 0
50 . 45 4 34 0
60 45 6 . 34 0
90 43 10 34 1
120 43 22 34 1
150 . 43 31 . 33 1
180 . 43 35 . 33 2
Extramammary tumours:
Stem cell leukaemia 0 . 3
Squamous carcinoma 3 2
Renal sarcoma
(embryonic type) 1 . 0
The Sprague-Dawley rats tolerated the 50 mg. of DMBA far better than the
Wistar rats, though some of them died 1 to 4 weeks after the administration of
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DMBA. It can be seen in Table III that mammary tumours developed in a high
percentage of the non-androgenised rats, though not as often or as rapidly as
reported by Huggins, Grand and Brillantes (1961) and by Huggins and Yang
(1962). Nevertheless, it is clear that a single oral administration of 50 mg. DMBA
provides a suitable method for the investigation of the importance of endocrine
factors in mammary carcinogenesis. It can be seen in Table III that the incidence
of the mammary tumours in the androgenised rats is less than in the non-andro-
genised rats and that the tumours appear later. Some extramammary tumours
including stem cell leukaemia also developed in occasional rats. These are also
listed in Table III.
As in Experiment I on Wistar rats, extensive adrenocortical necrosis was also
found in the Sprague-Dawley rats which died a few days after the oral administra-
tion ofDMBA. Some animals dying at 1 to 4 weeks showed the same lesion but in
a stage of repair with organisation, fibrous replacement and calcification of the
necrotic area, and with regeneration of surviving cells in the neighbourhood. In
many ofthe animals which survived over 5 months adrenocortical adenomata were
seen; the exact incidence can not be given as the adrenal glands were not cut in full
serial sections. The adenomata were well circumscribed small nodules, hardly
visible to the naked eye. They were composed of dark or vacuolated fasciculata
cells with cavernous blood vessels and dilated sinusoids filled with blood or
eosinophil secretion (Fig. 6).
Macroscopic and microscopic appearances of the mammnary tumnour8
The morphological characteristics of the mammary tumours which develop
after the oral administration of methylcholanthrene or DMBA have been described
by a number of authors (Dao and Sunderland, 1959; Huggins, Briziarelli and
Sutton, 1959; Daniel and Prichard, 1961 ; Huggins, Grand and Brillantes, 1961
EXPLANATION OF PLATES
FIG. 1.-Extensive infiltration of the liver by leucoblasts. H. and E. x 260.
FIG. 2. Numerous leucoblasts in the spleen. H. and E. x 440.
FIG. 3. Area of leucoblastic infiltration in the renal cortex. H. and E. x 110.
FIG,. 4. Focal leucoblastic infiltration of the adrenal gland. H. and E. x 110.
FIG. 5. Squamous cell carcinoma originating in Zymbal's gland. H. and E. x 110.
FIG. 6. Small adenoma of the adrenal cortex composed of dark fasciculata cells. H. and E.
x 110.
FIG. 7.-Poorly differentiated adenocarcinoma of the breast. H. and E. x 110.
FIG. 8. Adenocarcinoma of the breast. The tubules are lined by multiple layers of epithelial
cells. H. and E. xlI0.
FIG. 9. Cyst formation in a mammary tumour. H. and E. x 110.
FIG. 10. A solid area ofanaplastic carcinoma ofthe breast with many mitotic figures. H. and
E. x 440.
FIG. 11. A mammary tumour with a large amount of stroma which is infiltrated with inflam-
matory cells. H. and E. x 110.
FIG. 12.-Foci of necrosis in an adenocarcinoma of the mammary gland. H. and E. x 110.
FIG. 13. Milk-secreting adenoma of the mammary gland. H. and E. x 110.
FIG. 14. Fibroadenoma of the mammary gland. H. and E. x 110.
FIG. 15.- Fibroadenoma of the mammary gland. The fibrous component is well marked.
H. and E. x I 10.
FIG. 16. Ovary of an androgenised rat. Follicles of various sizes are seen, but there are no
corpora lutea. H. and E. x36.
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Young, Cowan and Sutherland, 1963; Daniel and Prichard, 1964). The tumours
occurring in the present material did not show any marked differences from those
found by other authors and a detailed histological description will not be given
here.
The tumours developed along the so called milk-line, where breast tissue is
normally present. The highest incidence was in the cervical or pectoral regions,
but many tumours occurred in the thoracic, abdominal or inguinal regions. Some
tumours grew quite rapidly and reached a considerable size, up to 4 or 5 cm. in
diameter; others grew slowly and remained small. The tumours were grossly
nodular, well circumscribed and moderately firm. In a few cases the tumours
ulcerated. Some rats had a single tumour only, but in several animals, 2, 3 or 4
tumours were present. Metastases were not observed.
Histologically the tumours had the structure of adenocarcinoma with various
degrees of differentiation (Fig. 7). Tubules lined by single or multiple layers of
epithelial cells were formed, frequently with eosinophil masses of secretion in the
lumina (Fig. 8). Papillary growths commonly projected into the lumen, and in
many tumours there was a conspicuous formation of cysts (Fig. 9). Sometimes
the tumour consisted of solid cell nests. Occasionally the so-called comedo-
pattern could be recognised. Some tumours were more anaplastic with numerous
mitotic figures (Fig. 10). The quantity of stroma varied between individual
tumours. Sometimes it was quite extensive, and was infiltrated to a varying
extent with mononuclear inflammatory cells (Fig. 11). Haemorrhages and foci of
necrosis were not infrequent (Fig. 12). Microscopic metastases were not seen, but
invasion of the neighbouring muscle was common.
In addition so-called milk-secreting adenomata developed in 4 of the non-
androgenised Sprague-Dawley rats which had one or two typical mammary
tumours as described above and in 1 of the androgenised Sprague-Dawley rats
which had no other mammary tumour. Tumours of this type have also been
reported by Daniel and Prichard (1964). These tumours consisted ofdilated acini
lined by a single layer of epithelial cells. The lumina were filled with a milk-like
basophilic material. Vacuoles were usually present in this colloid material and
also in the cytoplasm of the lining epithelium. The tumours had a histological
resemblance to the mammary glands of lactating animals, but there was usually
more fibrous stroma and the arrangement of the acini was somewhat irregular
(Fig. 13).
Typical fibroadenomata developed in the mammary glands in 7 animals (5 non-
androgenised Sprague-Dawley rats and 2 androgenised Sprague-Dawley rats)
(Fig. 14 and 15). These tumours are not listed in the tables.
None of these tumours showed any obvious histological difference between the
non-androgenised and the androgenised animals.
Histological changes in the androgenised rats
In the genital tract of the androgenised rats, typical changes were present
identical with those described by previous authors (Barraclough, 1961 ; Jacob-
sohn, 1964; Swanson and van der Werff ten Bosch, 1964; Kovacs, 1965). The
vaginal epithelium was cornified. The ovaries were small and contained follicles of
various sizes, some of which showed cystic dilatation. Corpora lutea were not
present (Fig. 16).
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DISCUSSION
It is well known that ovarian hormones exert a very important influence oln the
induction and growth of mammary tumours in experimental animals. Ovariec-
tomy or hypophysectomy markedly reduce the incidence and retard the growth of
mammary cancer caused by chemical carcinogens or radiation (Bielschowsky,
1944; Huggins, Briziarelli and Sutton, 1959; Cronkite, Shellabarger, Bond and
Lippincott, 1960; Kim and Furth, 1960b; Dao, 1962; Sydnor and Cockrell,
1963; Young, Cowan and Sutherland, 1963). Moreover, the administration of
oestrogens alone for long periods results in tumour production in the breast ofrats
(Geschickter, 1939; MacKenzie, 1955).
It is very difficult to decide the exact significance of the individual ovarian
hormones in the promotion of mammary tumours. Some authors emphasise the
importance of oestrogens (Geyer, Bryant, Bleisch, Peirce and Stare, 1953 ; Young,
Cowan and Sutherland, 1963). On the other hand numerous findings suggest that
progesterone has a more important role (Cantarow, Stasney and Paschkis, 1948;
Huggins, Briziarelli and Sutton, 1959; Sydnor and Cockrell, 1963).
The present experiments show that the incidence of mammary tumours is
definitely reduced in rats which have been androgenised by a single subcutaneous
injection of testosterone in early postnatal life. The exact hormonal status of
these androgenised rats has not yet been elucidated in detail. Nevertheless it
seems clear that they secrete oestrogens but little or no progesterone. Ifthis is so,
the present experiments suggest that a deficiency ofprogesterone has an inhibitory
effect on mammary carcinogenesis. It is necessary however to emphasise that this
does not rule out the possibility that other endocrine mechanisms may play a part
in this effect. For example, there is no information about the rate of luteotrophic
hormone secretion in androgenised rats or about the production of androgens by
the ovaries in these animals.
The present experiments show further that endocrine stimuli acting in the early
postnatal period are able to modify the susceptibility of the rat to carcinogenic
factors during later life. Further work is needed to test whether this concept is
of general significance.
SUTMMIARY
Oral administration of 50 mg. of IDMBA to female Sprague-Dawley rats causes
mammary cancer in a high percentage ofthe animals. The incidence ofthe breast
tumours is definitely reduced in androgenised rats, i.e. in rats which have received
a single subcutaneous injection of testosterone when they were 1 to 2 days old.
Wistar rats are far less suitable than Sprague-Dawley rats for the study of
mammary carcinogenesis induced by DMBA, because they are more susceptible to
other toxic effects of the drug. Nevertheless it seems probable that androgenisa-
tion reduces the incidence of the mammary tumours in this strain of rat also.
Stem cell leukaemia develops in some of the Wistar and Sprague-Dawley rats
treated with DMBA. Androgenisation does not reduce the incidence of the
leukaemia.
I am greatly indebted to Professor H. L. Sheehan for his interest help and
advice during this study. This work was carried out during the tenure of a
Crosby Research Fellowship of the North-West Cancer Research Fund.
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